Specialty code 183500000X · Boston, MA
NPI
1801583398
Since 2023
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
300 Longwood Ave
Boston, MA, 02115
Phone (617) 355-6000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.5M
150 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sarah Kubiak prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 125 prescriptions and refills. In total Sarah Kubiak wrote 150 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 125 | 125 | 17 | $3.1M |
| Kalydeco Ivacaftor | 17 | 17 | Under 11 | $401K |
Brand drugs: 150 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sarah Kubiak were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.